Claritas Rx Launches First and Only Care Coordination Platform for Specialty and Rare Disease Patients
Claritas Rx Launches First and Only Care Coordination Platform for Specialty and Rare Disease Patients
SaaS-based Patient Watchtower Uses AIML to Microtarget Patients Based on Risk Factors to Ensure They Receive Prompt Treatment
Webinar Entitled “Achieve Specialty Pharma Success with AI: Enhance Care, Elevate Fill Rates by 20% and Improve Patient Adherence” Planned for May 15
“Hyper-targeted coordination of disparate groups within a health enablement and access team (HEAT) allows biopharma companies to potentially increase their fill rate by 20%. For many specialty brands, this type of uplift can mean millions of dollars and more importantly, getting treatment to a patient faster,” said Mike Fitzgibbons, CEO of Claritas Rx. “Patient Watchtower gives life sciences companies unprecedented visibility into the prescription process, allowing them to quickly identify access issues and suggest the next best action to help patients start and stay on treatment.”
LAS VEGAS--(BUSINESS WIRE)--ASEMBIA AXS25 – Claritas Rx, the leader in technology and analytics to optimize the specialty patient experience, announced today the availability of Patient Watchtower, the first and only care coordination platform for specialty and rare disease patients. SaaS-based Patient Watchtower seamlessly merges complex and fragmented patient data from various sources and creates immediate actionable insights. It uses artificial intelligence and machine learning (AIML) to enable precise patient microtargeting based on risk factors, ensuring the patient will receive prompt treatment.
“Patient Watchtower gives life sciences companies unprecedented visibility into the prescription process, allowing them to quickly identify access issues and suggest the next best action to help patients start and stay on treatment.”
Share
Patient Watchtower manages the health enablement and access team (HEAT) of a patient, including case managers, specialty pharmacies, field teams, HUBs, other patient support call centers and any other resources biopharma companies would want to include. This coordination enables biopharma companies to leverage real-world, first-party data from care coordination organizations, making it instantly actionable for initiating patient support and interventions.
“Hyper-targeted coordination of disparate groups within a health enablement and access team (HEAT) allows biopharma companies to potentially increase their fill rate by 20%. For many specialty brands, this type of uplift can mean millions of dollars and more importantly, getting treatment to a patient faster,” said Mike Fitzgibbons, CEO of Claritas Rx. “Patient Watchtower gives life sciences companies unprecedented visibility into the prescription process, allowing them to quickly identify access issues and suggest the next best action to help patients start and stay on treatment.”
Specifically designed for Patient Services teams, Patient Watchtower offers:
- Tailored at-a-glance patient journey dashboard – customized to how the company envisions the patient journey
- Daily status updates providing Patient Services Teams visibility to high-priority patient cases requiring immediate attention
- Instant access to a patient’s detailed case history
- Shareable real-time information, enabling collaboration with partners
- Predictive analytics using machine learning on patient risk factors such as prescription discontinuation and abandonment
Webinar: Achieve Specialty Pharma Success with AI: Enhance Care, Elevate Fill Rates by 20% and Improve Patient Adherence
Claritas Rx is offering a webinar entitled “Achieve Specialty Pharma Success with AI: Enhance Care, Elevate Fill Rates by 20% and Improve Patient Adherence” that will include a detailed overview of Patient Watchtower.
When: May 15, 2025, at 1:00 p.m. ET (10:00 a.m. PT)
Where: Virtual – click here to register: Achieve Specialty Pharma Success with AI: Enhance Care, Elevate Fill Rates by 20% and Improve Patient Adherence
Who: Presented by Stuart Kamin, SVP, Analytics and Innovation at Claritas Rx and Karishma Desai, Solutions Consulting Engineer at Claritas Rx.
Media can RSVP to the webinar by contacting Elizabeth Marshall at emarshall@claritasrx.com.
About Patient Watchtower on the Claritas Rx Ascend ™ Platform
Patient Watchtower is part of the Claritas Rx Ascend™ platform. The Ascend platform allows seamless data input and set-up, simplifying patient risk assessments and intervention planning to optimize patient services. AIML is used for patient data management, strictly adhering to HIPAA, HITECH, GDPR and SOC2 regulations. Ascend utilizes hundreds of predictive factors to provide a comprehensive perspective for informed decision-making for Field Access Teams to take the next best action.
Patient Watchtower transforms raw data into actionable insights to uncover hidden narratives behind the data. With Patient Watchtower, companies can understand why a patient might drop off treatment and stay one step ahead in offering the help they need.
About Claritas Rx
Based in South San Francisco, CA, Claritas Rx is a technology company focused on managing real world data focused on specialty biopharmaceutical distribution channels in oncology and rare/orphan diseases. Since 2011 the company has illuminated brand performance and the patient journey for dozens of therapies. Claritas Rx creates actionable business intelligence that helps manufacturers more effectively go to market and enhance the patient experience. For more information visit www.claritasrx.com.
Contacts
Media Contact: Elizabeth Marshall, emarshall@claritasrx.com
